NO853732L - PROCEDURE FOR PREPARATION OF PYRAZOLONE DERIVATIVES. - Google Patents

PROCEDURE FOR PREPARATION OF PYRAZOLONE DERIVATIVES.

Info

Publication number
NO853732L
NO853732L NO853732A NO853732A NO853732L NO 853732 L NO853732 L NO 853732L NO 853732 A NO853732 A NO 853732A NO 853732 A NO853732 A NO 853732A NO 853732 L NO853732 L NO 853732L
Authority
NO
Norway
Prior art keywords
residue
alkyl
atoms
group
alkoxy
Prior art date
Application number
NO853732A
Other languages
Norwegian (no)
Inventor
Paul Naab
Werner Ertel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO853732L publication Critical patent/NO853732L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

Oppfinnelsen vedrører en forbedret fremstillingsmåte for 1-substituerte 3-amino-pyrazolon-(5), idet i et første trinn 4 kondenseres et hydrazinderivat surt med 8-amino-B-alkoksy-akrylsyrealkylester og mellomproduktet underkastes i et annet trinn i sterkt basisk miljø ved temperaturer under 10°C for en ringslutningsreaksjon. The invention relates to an improved preparation method for 1-substituted 3-amino-pyrazolone-(5), in that in a first step 4, a hydrazine derivative is condensed acidic with 8-amino-B-alkoxy-acrylic acid alkyl ester and the intermediate product is subjected in a second step to a strongly basic environment at temperatures below 10°C for a ring closure reaction.

3-amino-pyrazolon-(5)-derivater og fremgangsmåte til deres fremstilling omtales i DE-OS 2 319 280. Forbindelsene har en utpreget diuretisk og antihypertensiv effekt, idet 3-amino-l--metyl-4-klorbenzyl)-pyrazolon-(5) ("Muzolimin") har vist seg som verdifullt. Med hensyn til den farmako-logiske virkning av muzolimin skal det f.eks. henvises til Recent Advances in Diuretic Therapy: Proe. of the Sec. Int.Edrul Symposium (1983), utgitt av V.E. Andreucci, Excerpta Medica, Amsterdam, til Clin. Nephrol. 19 (1983): Suppl. 1, Loew et al in Eur. J. Clin. Pharmacol., 12 (1977), S. 341-344 og den der siterte litteratur. 3-amino-pyrazolone-(5)-derivatives and the process for their preparation are described in DE-OS 2 319 280. The compounds have a pronounced diuretic and antihypertensive effect, since 3-amino-1-methyl-4-chlorobenzyl)-pyrazolone -(5) ("Muzolimin") has proven valuable. With regard to the pharmacological effect of muzolimin, it shall e.g. refer to Recent Advances in Diuretic Therapy: Proe. of the Sec. Int. Edrul Symposium (1983), published by V.E. Andreucci, Excerpta Medica, Amsterdam, to Clin. Nephrol. 19 (1983): Suppl. 1, Loew et al in Eur. J. Clin. Pharmacol., 12 (1977), pp. 341-344 and the literature cited therein.

Amino-pyrazolonene fåes ifølge DE-OS 2 319 280 ved omset-ning av det tilsvarende hydrazin med et egnet eddiksyrederivat, eventuelt i nærvær av inert-:-. oppløsningsmiddel og basiske eller sure katalysatorer som alkali- og jordalkalihydroksyder og -karbonater eller som halogenhydrogensyrer, svovelsyre eller sulfonsyrer, ved temperaturer mellom 10 og 200°C. Muzolimin fåes ifølge eksempel 9 i DE-OS 2 319 280, idet 6-amino-g-etoksyakrylsyreetylester og p-toluensulfonsyrer blandes i absolutt alkohol dråpevis med a-metyl-3,4-diklorbenzylhydrazin, blandingen omrøres, hen-settes natten over og alkoholen avdampes. Residuet opp-løses i 2n-NaOH og befris for forurensninger ved ekstrahering med eter. Den vandige fase bringes med eddiksyre til pH 5, den dannede olje opptas i meytlenklorid, tørkes og oppløsningsmidlet avdampes. The amino-pyrazolones are obtained according to DE-OS 2 319 280 by reacting the corresponding hydrazine with a suitable acetic acid derivative, optionally in the presence of inert -:-. solvent and basic or acidic catalysts such as alkali and alkaline earth hydroxides and carbonates or as hydrohalic acids, sulfuric acid or sulphonic acids, at temperatures between 10 and 200°C. Muzolimin is obtained according to example 9 in DE-OS 2 319 280, whereby 6-amino-g-ethoxyacrylic acid ethyl ester and p-toluenesulfonic acids are mixed in absolute alcohol dropwise with α-methyl-3,4-dichlorobenzylhydrazine, the mixture is stirred, allowed to stand overnight and the alcohol evaporates. The residue is dissolved in 2n-NaOH and freed from impurities by extraction with ether. The aqueous phase is brought to pH 5 with acetic acid, the oil formed is taken up in methyl chloride, dried and the solvent is evaporated.

Den i DE-OS 2 319 280 omtalte fremgangsmåte har en rekke ulemper: Det dannede produkt er gulaktig, og utbyttene er, fremfor alt ved overføring i teknisk målestokk, små (ca. 20-25%). Det var således foreliggende oppfinnelses oppgave å finne en teknisk enkel syntesefremgangsmåte for amino-pyrazoloner, som muliggjør høye utbytter av fargemessig uklanderlig -produkt også i storteknisk blanding. Denne oppgave løses med fremgangsmåten ifølge oppfinnelsen. The method mentioned in DE-OS 2 319 280 has a number of disadvantages: The product formed is yellowish, and the yields are, above all when transferred on a technical scale, small (approx. 20-25%). It was thus the task of the present invention to find a technically simple synthesis method for amino-pyrazolones, which enables high yields of color-impeccable product also in large-scale technical mixtures. This task is solved with the method according to the invention.

Oppfinnelsens oppgave er en fremgangsmåte til fremstilling av pyrazolonderivater med formel: The task of the invention is a method for the preparation of pyrazolone derivatives with the formula:

R betyr hydrogen, alkyl, alkenyl eller eventuelt substituert aryl eller aralkyl, 2 R betyr en alkylrest, og R 3 betyr en eventuelt substituert arylrest, som inneholder inntil to like eller forskjellige substituenter fra gruppen hakogen, trifluormetyl, alkyl, alkenyl, alkoksy eller inneholder en alkylamino-, trifluormetoksy-, nitro-, cyJ ano-, karbonamino-, sulfonamido- eller SO n-alkylrest (n = 0-2), eventuelt sammen med en eller to substituenter fra gruppen alkyl, alkenyl, alkoksy, halogen eller trifluormetyl, idet eventuelt to substituenter ved arylresten sammen danner en forgrenet eller uforgrenet, mettet eller umettet 5- til 7-leddet isocyklisk eller heterocyklisk ring, som på sin side kan inneholde 1-2 oksygenatomer eller svovelatomer,idet et hydrazin med formel R means hydrogen, alkyl, alkenyl or optionally substituted aryl or aralkyl, 2 R means an alkyl residue, and R 3 means an optionally substituted aryl residue, which contains up to two identical or different substituents from the group hacogen, trifluoromethyl, alkyl, alkenyl, alkoxy or contains an alkylamino-, trifluoromethoxy-, nitro-, cyano-, carbonamino-, sulfonamido- or SO n-alkyl residue (n = 0-2), optionally together with one or two substituents from the group alkyl, alkenyl, alkoxy, halogen or trifluoromethyl, where optionally two substituents at the aryl residue together form a branched or unbranched, saturated or unsaturated 5- to 7 -membered isocyclic or heterocyclic ring, which in turn may contain 1-2 oxygen atoms or sulfur atoms, whereas a hydrazine of formula

hvori R 2 og R 3 har ovennevnte betydning, omsettes med et eddiksyrederivat med formel hvori R"'" har ovennevnte betydning, X betyr en hydroksy-, alkoksy-, aralkoksy-, amino- eller alkylaminorest og Y betyr en alkoksy-, aryloksy-, aralkoksy-, alkylmerkapto-eller aralkylmerkaptorest eller en aminogruppe, i nærvær av basiske eller sure katalysatorer, samt eventuelt inert oppløsningsmiddle, idet fremgangsmåten er karakterisert ved at a) eddiksyrederivatet (III) anvendes i form av et salt med en sterk syre, b) saltet av eddiksyrederivatet (III) kondenseres med hydrazinet (II) i et første trinn i nærvær av 0,1-2,0 ekvivalenter av en svak base i et fortrinnsvis vandig reaksj onsmedium, c) det dannede mellomprodukt viderekondenseres med en konsentrert vandig oppløsning av en sterk base, idet reaksjonstemperaturen holdes under 10°C, og d) reaksjonsproduktet utfelles ved innstilling av en pH-verdi fra 0-3,5 ved hjelp av en sterk vandig syre. in which R 2 and R 3 have the above meaning, is reacted with an acetic acid derivative of formula in which R"'" has the above meaning, X means a hydroxy, alkoxy, aralkyl, amino or alkylamino residue and Y means an alkoxy, aryloxy, aralkyloxy, alkylmercapto or aralkylmercapto residue or an amino group, in the presence of basic or acidic catalysts, as well as any inert solvent, in that the method is characterized by a) the acetic acid derivative (III) is used in the form of a salt with a strong acid, b) the salt of the acetic acid derivative (III) is condensed with the hydrazine (II) in a first step in the presence of 0.1-2.0 equivalents of a weak base in a preferably aqueous reaction medium, c) the intermediate product formed is further condensed with a concentrated aqueous solution of a strong base, keeping the reaction temperature below 10°C, and d) the reaction product is precipitated by setting a pH value from 0-3.5 using a strong aqueous acid.

Fortrinnsvis befris mellomproduktet fra første trinn av fremgangsmåten ifølge oppfinnelsen dessuten i surt miljø ved ekstrahering ved hjelp av et organisk oppløsningsmiddel for forurensning og biprodukter. Fortrinnsvis isoleres ikke mellomprodukter fra reaksjonsblandingen, men omsettes direkte videre i form av en enbeholderes-reaksjon i annet trinn videre. Preferably, the intermediate product from the first step of the method according to the invention is also freed in an acidic environment by extraction using an organic solvent for contamination and by-products. Preferably, intermediate products are not isolated from the reaction mixture, but reacted directly further in the form of a one-pot reaction in the second step.

I formel I betyr fortrinnsvisIn formula I means preferably

R1 hydrogen, en alkyl- eller alkenylrest med inntil 4 C-atomer, en fenyl- eller benzylgruppe, som eventuelt er substituert med en alkoksygruppe med 1-2 C-atomer, spesielt foretrukket hydrogen, R1 hydrogen, an alkyl or alkenyl radical with up to 4 C atoms, a phenyl or benzyl group, which is optionally substituted with an alkoxy group with 1-2 C atoms, particularly preferably hydrogen,

R 2 en alkylrest med 1-4 karbonatomer, spesielt foretrukket metyl, og R 2 an alkyl radical with 1-4 carbon atoms, particularly preferably methyl, and

R 3 en fenyl- eller naftylrest, spesielt en fenylrest, som kan være substituert med 1-2 rettlinjede eller forgrenede alkyl- eller alkenylrester med inntil 8 karbonatomer, spesielt med 1-2 alkylrester med 1-4 karbonatomer, eller fortrinnsvis med 1-2 alkoksyrester med inntil 6 karbonatomer, spesielt med inntil 4 karbonatomer, eller med 1 cykloalkyl- eller cykloalkenylrest med 5-7 karbonatomer, eller med 1-2 halogenatomer som fluor, klor eller brom eller med 1-2 trifluormetylrester eller med en trifluormetoksy-, nitro-, cyanogruppe eller en dialkylamino-, karbonamido- eller sulfonamidogruppe, hvis nitrogenatom kan være substituert ved 1 eller 2 rettlinjede eller forgrenede alkylgrupper med respektivt 1-4 C-atomer, og idet ovennevnte alkylgrupper sammen med nitrogenatomet kan danne en 5- til 7-leddet heterocyklisk ring som kan inneholde et oksygenatom.som ekstra heteroatom, eller er substituert med en SOn~alkylgruppe, idet n betyr 0-2, spesielt 0 eller 2, og alkylresten er rettlinjet eller forgrenet og inneholder 1-4 karbonatomer, og idet 2 substituenter ved fenyl- eller naftylringen sammen kan danne en forgrenet eller uforgrenet, mettet eller umettet 5- til 7-leddet isocyklisk eller heterocyklisk ring, som kan inneholde 1 svovel- eller 1-2 oksygenatomer. R 3 a phenyl or naphthyl residue, especially a phenyl residue, which may be substituted with 1-2 straight or branched alkyl or alkenyl residues with up to 8 carbon atoms, especially with 1-2 alkyl residues with 1-4 carbon atoms, or preferably with 1-2 Alkoxide residues with up to 6 carbon atoms, especially with up to 4 carbon atoms, or with 1 cycloalkyl or cycloalkenyl residue with 5-7 carbon atoms, or with 1-2 halogen atoms such as fluorine, chlorine or bromine or with 1-2 trifluoromethyl residues or with a trifluoromethoxy-, nitro -, cyano group or a dialkylamino-, carbonamido- or sulfonamido group, whose nitrogen atom can be substituted by 1 or 2 linear or branched alkyl groups with respectively 1-4 C-atoms, and the above-mentioned alkyl groups together with the nitrogen atom can form a 5- to 7- membered heterocyclic ring which may contain an oxygen atom as an additional heteroatom, or is substituted with a SOn~alkyl group, where n means 0-2, especially 0 or 2, and the alkyl residue is linear or branched and contains 1-4 carbon atoms, and since 2 substituents at the phenyl or naphthyl ring together can form a branched or unbranched, saturated or unsaturated 5- to 7-membered isocyclic or heterocyclic ring, which can contain 1 sulfur or 1-2 oxygen atoms .

I formel III betyr fortrinnsvisIn formula III preferably means

X hydroksyl, en eventuelt forgrenet alkoksygruppe med 1-6 X hydroxyl, an optionally branched alkoxy group with 1-6

C-atomer, spesielt 1-3 C-atomer, en benzyloksy-, en amino-, alkylamino- eller dialkylaminogruppe med respektivt 1-4 C-atomer pr. alkylgruppe og C atoms, especially 1-3 C atoms, a benzyloxy, an amino, alkylamino or dialkylamino group with respectively 1-4 C atoms per alkyl group and

Y en alkoksy- eller alkylmerkaptorest med respektivt 1-6 C-atomer i alkylgruppen, spesielt en alkoksyrest med 1-3 C-atomer, eller en benzyloksy-, fenoksy-, benzylmerkaptorest eller en aminogruppe. Y an alkoxy or alkylmercaptor residue with respectively 1-6 C atoms in the alkyl group, especially an alkoxy acid residue with 1-3 C atoms, or a benzyloxy, phenoxy, benzylmercaptor residue or an amino group.

Eksempler for ifølge oppfinnelsen fremstillbare forbindelser med formel I resp. utgangsforbindelser med formel II og III er angitt i DE-OS 2 319 280. Examples of compounds with formula I or starting compounds of formula II and III are disclosed in DE-OS 2 319 280.

Forbindelse III, idet følgende nevnt "Imidoester", anvendes i fremgangsmåten ifølge oppfinnelsen som salt av en sterk syre, (K^>• 1), fortrinnsvis en mineralsyre (spesielt saltsyre ) . Compound III, the following mentioned "Imido ester", is used in the method according to the invention as a salt of a strong acid, (K^>• 1), preferably a mineral acid (especially hydrochloric acid).

Saltet av imidoesteren omsettes i første trinn av fremgangsmåten ifølge oppfinnelsen med hydrazinet II, fortrinnsvis i et vandig reaksjonsmedium i nærvær av 0,1-2,0 ekvivalenter av en svak base, fortrinnsvis med 0,4-0,6 ekvivalenter. Egnede svake baser er f.eks. salter av karboksylsyre eller aminer. The salt of the imidoester is reacted in the first step of the process according to the invention with the hydrazine II, preferably in an aqueous reaction medium in the presence of 0.1-2.0 equivalents of a weak base, preferably with 0.4-0.6 equivalents. Suitable weak bases are e.g. salts of carboxylic acid or amines.

Foretrukket er salter av karboksylsyrer, spesielt Na-acetat. Reaksjonstemperaturen ligger mellom -20°C og +50°C, fortrinnsvis mellom 10°C og 30°C. Salts of carboxylic acids, especially Na acetate, are preferred. The reaction temperature is between -20°C and +50°C, preferably between 10°C and 30°C.

Reaksjonsblandingen i første trinn av fremgangsmåten ifølge oppfinnelsen kan eventuelt inneholde et med vann blandbart organisk oppløsningsmiddel. The reaction mixture in the first step of the method according to the invention may optionally contain a water-miscible organic solvent.

Eksempler herpå er metanol, etanol, isopropanol, tetra-hydrofuran eller dioksan. Examples of this are methanol, ethanol, isopropanol, tetrahydrofuran or dioxane.

Foretrukket er den eller di alkoholer som tilsvarer alkoksyresten eller restene av imidoesteren. Reaksjonsblandingens første trinn av fremgangsmåten ifølge oppfinnelsen befries fortrinnsvis ved den ovennevnte svakt sure pH ved ekstrahering ved hjelp av et organisk oppløs-ningsmiddel av biprodukter og ikke omsatte utgangsprodukter. Egnede oppløsningsmidler er f.eks. betroleter, eter, metylenklorid eller toluen. The alcohol or alcohols corresponding to the alkoxy residue or residues of the imidoester are preferred. The reaction mixture's first step of the method according to the invention is preferably freed at the above-mentioned slightly acidic pH by extraction with the aid of an organic solvent of by-products and unreacted starting products. Suitable solvents are e.g. petroleum ether, ether, methylene chloride or toluene.

Foretrukket er toluen.Toluene is preferred.

Etter adskillelse av den organiske fase fra ekstraherings-trinnet underkastes den vandige fase fortrinnsvis direkte, dvs. uten isolering av mellomproduktet for den alkaliske kondensasjonsreaksjon. Dette foregår ved tilsetning av en konsentrert sterk base (K<>>1), således at reaksjonsblandingen inneholder 1-10 vekt-%, fortrinnsvis 2-5 vekt-% på den sterke base. Som sterke baser kommer det fortrinnsvis i be-traktning alkali- og jordalkalihydroksyder, spesielt NaOH og KOH. Under den alkaliske kondensasjonsreaksjon skal reaksjonsblandingens temperatur ligge under 10°C, fortrinnsvis mellom -15°C og 5°C, spesielt ved ca. 0°C. Reaksjons-varigheten utgjør fortrinnsvis mindre enn 1 time, spesielt foretrukket 10-30 minutter. After separation of the organic phase from the extraction step, the aqueous phase is preferably subjected directly, i.e. without isolation of the intermediate product for the alkaline condensation reaction. This takes place by adding a concentrated strong base (K<>>1), so that the reaction mixture contains 1-10% by weight, preferably 2-5% by weight of the strong base. Strong bases preferably include alkali and alkaline earth hydroxides, especially NaOH and KOH. During the alkaline condensation reaction, the temperature of the reaction mixture must be below 10°C, preferably between -15°C and 5°C, especially at approx. 0°C. The reaction duration is preferably less than 1 hour, particularly preferably 10-30 minutes.

Reaksjonsblandingen innstilles deretter ved tilsetning av en sterk syre (f.eks. de ovenfor ved imidoester-saltet nevnte syrer) på en pH-verdi fra 0-3,5, fortrinnsvis 1-2,5, spesielt ca. 1,5-2, idet reaksjonsproduktet faller ut. Råproduktet kan renses videre ved omkrystallisering, f.eks. fra vandig alkohol. The reaction mixture is then adjusted by adding a strong acid (e.g. the acids mentioned above for the imidoester salt) to a pH value of 0-3.5, preferably 1-2.5, especially approx. 1.5-2, as the reaction product precipitates out. The crude product can be further purified by recrystallization, e.g. from aqueous alcohol.

Syntesefremgangsmåten ifølge oppfinnelsen har i forhold til de i DE-OS 2 319 280 omtalte fremgangsmåte en rekke for-deler : 1) Imidoesteren anvendes direkte som salt av en sterk syre, dvs. i den storteknisk dannede form, imidoesteren behøver således ikke å bli fremstilt ren, hvilket innsparer et trinn. 2) Etter det sure kondensasjonstrinn avdestilleres intet organisk oppløsningsmiddel, dvs. det spares tid og energi, og produktet belastes ikke termisk. 3) Ved ekstraheringen ved sur pH etter det sure kondensasjonstrinn fjernes biprodukter og ikke omsatt utgangs-material. 4) Den alkaliske kondensasjon (cyklisering) viser seg bedre beherskbar og reproduserbar ved temperaturer under 10°C. 5) Ved innstillingen av en sterk sur pH etter den alkaliske kondensasjon fjernes vesentlig bedre biprodukter som f.eks. 3-N(3,4-diklor-a <-> metylbenzyl)-acet-amidrazon IV dette er ikke tilfellet ved surgjøring med eddiksyre. 6) Reaksjonsprodukte har vesentlig bedre fargekvalitet og fåes i utbytter på over 50%. 7) Den samlede fremstillingsfremgangsmåte er tidsmessig hurtigere og teknisk enklere gjennomførbar.The synthesis method according to the invention has a number of advantages compared to the methods mentioned in DE-OS 2 319 280: 1) The imidoester is used directly as a salt of a strong acid, i.e. in the high-tech form, the imidoester thus does not need to be prepared pure, which saves a step. 2) After the acid condensation step, no organic solvent is distilled off, i.e. time and energy are saved, and the product is not subjected to thermal stress. 3) During the extraction at acidic pH after the acidic condensation step, by-products and unreacted starting material are removed. 4) The alkaline condensation (cyclization) proves to be more manageable and reproducible at temperatures below 10°C. 5) By setting a strongly acidic pH after the alkaline condensation, by-products such as e.g. 3-N(3,4-dichloro-a <-> methylbenzyl)-acetamidrazone IV this is not the case with acidification with acetic acid. 6) The reaction product has significantly better color quality and is obtained in yields of over 50%. 7) The overall manufacturing process is faster in terms of time and technically easier to implement.

Eksempel_l_£ifØl2§_2E£fiDD?i§erOExample_l_£ifØl2§_2E£fiDD?i§erO

a) Fremstilling av hydrazinet (II): a) Preparation of the hydrazine (II):

1,2-diklor-4-(1-kloretyl)-benzen omsettes med hydrazinhydrat i et med vann blandbart oppløsningsmiddel, f.eks. etanol, ved oppvarming til N-/I-(3,4-diklorfenyl)-etyl/-hydrazin. Etter adskillelse av det dannede hydrazinhydroklorid vaskes reaksjonsblandingen med vann. Det således dannede hydrazin kan videreforarbeides direkte, dvs. uten ytterligere rensing. 1,2-dichloro-4-(1-chloroethyl)-benzene is reacted with hydrazine hydrate in a water-miscible solvent, e.g. ethanol, on heating to N-(1-(3,4-dichlorophenyl)-ethyl)-hydrazine. After separation of the hydrazine hydrochloride formed, the reaction mixture is washed with water. The hydrazine thus formed can be further processed directly, i.e. without further purification.

b) Fremstilling av muzolimin: 142 vektdeler 2-metyl-3,4-diklorbenzylhydrazin (råmaterial fra trinn a) blandes med 60 volumdeler vann. Deretter til-setter man hertil 69,5 vektdeler natriumacetat-trihydrat og i løpet av 10 minutter 103,5 vektdeler imidoesterhydroklorid. Nå etteromrøres i 25 minutter. Deretter tilsettes 385 volumdeler etanol, gjennomrøres i 10 minutter og frafiltreres fra uoppløst. Filtratet utrøres med 375 volumdeler vann og 600 volumdeler toluen og den organiske fase adskilles. Den vandige fase utrøres igjen med 600 volumdeler toluen og avkjøles etter adskillelse av toluen til-5°C. Nå tilsettes i løpet av 10 minutter under avkjøling en blanding av 82,8 vektdeler45%-ig natronlut og 128,1 volumdeler vann, og.omrøres ytterligere ved 5°C. Denne oppløsning innstilles deretter med 140 volumdeler av en blanding av 154,7 vektdeler saltsyre (ren, 37%-ig) og 46,5 volumdeler vann på pH 1,5, idet 3-amin-1-(3,4-diklor-a-metylbenzyl)-2-pyrazolin-5-on faller ut. Det tilsettes enda 750 volumdeler vann og krystallisatet isoleres. Det fuktige råmaterial omkrystalliseres fra brennevin/vann og tørkes. Man får 77 vektdeler 3-amino-l-(3,4-diklor-a-metylbenzyl)-2-pyrazolin-5-on av smeltepunkt 137°C (51,8% av det teoretiske). b) Production of muzolimin: 142 parts by weight of 2-methyl-3,4-dichlorobenzylhydrazine (raw material from step a) are mixed with 60 parts by volume of water. 69.5 parts by weight of sodium acetate trihydrate and 103.5 parts by weight of imidoester hydrochloride are then added within 10 minutes. Now stir for 25 minutes. 385 parts by volume of ethanol are then added, stirred for 10 minutes and filtered off from undissolved. The filtrate is stirred with 375 parts by volume of water and 600 parts by volume of toluene and the organic phase is separated. The aqueous phase is stirred again with 600 parts by volume of toluene and cooled after separation of the toluene to -5°C. A mixture of 82.8 parts by weight of 45% caustic soda and 128.1 parts by volume of water is now added during 10 minutes while cooling, and stirred further at 5°C. This solution is then adjusted with 140 parts by volume of a mixture of 154.7 parts by weight of hydrochloric acid (pure, 37% strength) and 46.5 parts by volume of water at pH 1.5, whereby 3-amine-1-(3,4-dichloro- α-methylbenzyl)-2-pyrazolin-5-one precipitates. A further 750 parts by volume of water are added and the crystallisate is isolated. The moist raw material is recrystallized from spirits/water and dried. 77 parts by weight of 3-amino-1-(3,4-dichloro-a-methylbenzyl)-2-pyrazolin-5-one of melting point 137°C (51.8% of the theoretical) are obtained.

Ek s emge 1 _2 Sammen ligning)_Ek s emge 1 _2 Together equation)_

a) Fremstilling av imidoester 109,2 g natriumhydrogenkarbonat oppløses i 1,16 1 vann og overhelles med 280 ml toluen. Nå tilsettes 195,7 g imidoesterhydroklorid porsjonsvis og etteromrøres i 5 minutter inntil det ikke mer er å iaktta noen karbon-dioksydutvikling.. Vannfasen adskilles og ekstraheres igjen med 140 ml. De forenede toluenfaser tørkes med natriumsulfat, natriumsulfatet frasuges og toluen inn-dampes på rotasjonsfordamper. Man får 154,2 g (96,9% av det teoretiske) av rått imidoester. Imidoesteren ble destillert i høyvakuum, 129,6 g (kokepunkt = 59-63°C, 81,4% av det teoretiske). a) Preparation of imido ester Dissolve 109.2 g of sodium bicarbonate in 1.16 1 of water and pour over 280 ml of toluene. Now 195.7 g of imidoester hydrochloride are added in portions and stirred for 5 minutes until no more carbon dioxide evolution can be observed. The water phase is separated and extracted again with 140 ml. The combined toluene phases are dried with sodium sulphate, the sodium sulphate is sucked off and the toluene is evaporated on a rotary evaporator. 154.2 g (96.9% of the theoretical) of crude imidoester are obtained. The imido ester was distilled in high vacuum, 129.6 g (boiling point = 59-63°C, 81.4% of theory).

b) Fremstilling av muzolimin ifølge DE-OS 2 319 280: b) Production of muzolimin according to DE-OS 2 319 280:

Til en oppløsning av 31,8 g imidoester og 1,5 g para-toluensulfonsyre i 150 ml etanol ble det i løpet av 18 minutter tildryppet 41 g a-metyl-3,4-diklorbenzyl-hydrazin (rå), oppløst i 50 ml etanol (temperatur To a solution of 31.8 g of imidoester and 1.5 g of para-toluenesulfonic acid in 150 ml of ethanol, 41 g of α-methyl-3,4-dichlorobenzyl-hydrazine (crude), dissolved in 50 ml, were added dropwise over the course of 18 minutes ethanol (temp

økte til 27°C, oppløsningen ble uklar). Deretter om-rørte man enda i 2 timer og lot det stå natten over (oppløsning uklar, faststoff). Neste morgen ble opp-løsningsmidlet avdampet i vakuum (bad 25°C, slutt-trykk 16 mbar, tid: 30 minutter, residu: orangefarget olje, 73,5 g, inneholder faststoff), og residuet oppløst i 200 ml 2 n natronlut (temperatur økte til 30°C, igjen 'avkjølt til 20°C, omrørt 10 minutter). Den vandige fase ble ekstrahert tre ganger med hver gang 100 ml dietyleter og etter adskillelse av den vandige fase innstilt med 30 ml eddiksyre på pH 5,0. Nå ble det tilsatt 100 ml metylenklorid og frasuget fra faststoff som ikke går i oppløsning. increased to 27°C, the solution became cloudy). The mixture was then stirred for another 2 hours and left to stand overnight (unclear solution, solid). The next morning, the solvent was evaporated in vacuo (bath 25°C, final pressure 16 mbar, time: 30 minutes, residue: orange-coloured oil, 73.5 g, contains solid), and the residue dissolved in 200 ml of 2 N caustic soda ( temperature increased to 30°C, again 'cooled to 20°C, stirred 10 minutes). The aqueous phase was extracted three times with 100 ml of diethyl ether each time and, after separation of the aqueous phase, adjusted to pH 5.0 with 30 ml of acetic acid. Now 100 ml of methylene chloride was added and the solid which does not dissolve was filtered off with suction.

Faststoffet (24,5 g tilsvarende 45% av det teoretiske) ble spylt to ganger med 25 ml metylenklorid og de forenede, adskilte metylenkloridfaser ble tørket med natriumsulfat. Etter adskillelse av natriumsulfatet ble metylenkloridet fjernes i vakuum (residu: seig olje, delvis krystallinsk, 23,7 g) og residuet omkrystallisert med det på forhånd frasugede faste stoff fra 35 ml varm metanol. Etter avkjøling, frasuging, vasking med metanol og tørking kunne det isoleres 22,8 g (40,5% av det teoretiske) krystallinsk material. The solid (24.5 g corresponding to 45% of the theoretical) was rinsed twice with 25 ml of methylene chloride and the combined, separated methylene chloride phases were dried with sodium sulfate. After separation of the sodium sulfate, the methylene chloride was removed in vacuo (residue: viscous oil, partially crystalline, 23.7 g) and the residue recrystallized with the previously aspirated solid from 35 ml of hot methanol. After cooling, suction, washing with methanol and drying, 22.8 g (40.5% of the theoretical) crystalline material could be isolated.

Produktet har en gulaktig misfarging som heller ikke kunne fjernes ved omkrystallisering fra etanol/vann. The product has a yellowish discoloration which could not be removed by recrystallization from ethanol/water either.

j- j-

Claims (10)

1. Fremgangsmåte til fremstilling av pyrazolonderivater med formel 1. Process for the preparation of pyrazolone derivatives with formula R"^ betyr hydrogen, alkyl, alkenyl eller eventuelt substituert aryl eller aralkyl, 2 R betyr en alkylrest og R^ betyr en eventuelt substituert arylrest, som inneholder inntil to like eller forskjellige substituenter fra gruppen halogen, trifluormetyl, alkyl, alkenyl, alkoksy eller inneholder en alkylamino-, trifluormetoksy-, nitro-, cyano-, karbonamino-, sulfonamido- eller S0n~ alkylrest (n = o-2), eventuelt sammen med 1 eller 2 substituenter fra gruppen alkyl, alkenyl, alkoksy, halogen eller triflurometyl, idet eventuelt to substituenter ved arylresten sammen danner en forgrenet eller uforgrenet, mettet eller umettet, 5- til 7-leddet isocyklisk eller heterocyklisk ring, som på sin side kan inneholde 1-2 oksygen- eller svovelatomer, idet et hydrazin med formel 2 3 hvori R og R har ovennevnte betydning, omsettes med et eddiksyrederivat med formel R"^ means hydrogen, alkyl, alkenyl or optionally substituted aryl or aralkyl, 2 R means an alkyl residue and R^ means an optionally substituted aryl residue, which contains up to two identical or different substituents from the group halogen, trifluoromethyl, alkyl, alkenyl, alkoxy or contains an alkylamino-, trifluoromethoxy-, nitro-, cyano-, carbonamino-, sulfonamido- or S0n~ alkyl residue (n = o-2), optionally together with 1 or 2 substituents from the group alkyl, alkenyl, alkoxy, halogen or trifluromethyl, with optionally two substituents at the aryl residue together forming a branched or unbranched, saturated or unsaturated, 5- to 7- membered isocyclic or heterocyclic ring, which in turn may contain 1-2 oxygen or sulfur atoms, whereby a hydrazine of formula 2 3 in which R and R have the above meaning is reacted with an acetic acid derivative of formula hvori R har ovennevnte betydning, X betyr en hydroksy-, alkoksy-, aralkoksy-, amino-eller alkylaminorest og Y betyr en alkoksy-, aryloksy-, aralkoksy-, alkyl-merkapto- eller aralkylmerkaptorest eller en aminogruppe, i nærvær av basiske eller sure katalysatorer samt eventuelt inert oppløsningsmiddel, karakterisert ved a) eddiksyrederivatet (III) anvendes i form av dets " . salt med en sterk syre, b) eddiksyrederivatet (III ) kondenseres med hydrazinet (II) i et første trinn i nærvær av en svak base i et fortrinnsvis vandig reaksjonsmedium, c) det dannede mellomprodukt viderekondenseres med en konsentrert vandig oppløsning av en sterk base, idet reaksjonstemperaturen holdes under 10°C, og d) reaksjonsproduktet utfelles ved innstilling av en pH-verdi fra 0-3,5 ved hjelp av en sterk vandig syre.in which R has the above meaning, X means a hydroxy, alkoxy, aralkyl, amino or alkylamino residue and Y means an alkoxy, aryloxy, aralkoxy, alkyl mercapto or aralkyl mercapto residue or an amino group, in the presence of basic or acidic catalysts as well as any inert solvent, characterized by a) the acetic acid derivative (III) is used in the form of its salt with a strong acid, b) the acetic acid derivative (III) is condensed with the hydrazine (II) in a first step in the presence of a weak base in a preferably aqueous reaction medium, c) the intermediate product formed is further condensed with a concentrated aqueous solution of a strong base, keeping the reaction temperature below 10°C, and d) the reaction product is precipitated by setting a pH value from 0-3.5 using a strong aqueous acid. 2. Fremgangsmåte ifølge krav 1, karakterisert ved at R <1> betyr hydrogen, en alkyl- eller alkenylrest med inntil 4 C-atomer, en fenyl- eller benzylgruppe, som eventuelt er substituert med en alkoksygruppe med 1-2 C-atomer, spesielt hydrogen.2. Method according to claim 1, characterized in that R <1> means hydrogen, an alkyl or alkenyl residue with up to 4 C atoms, a phenyl or benzyl group, which is optionally substituted with an alkoxy group with 1-2 C atoms, especially hydrogen. 3. Fremgangsmåte ifølge krav 1 eller 2, karakterisert ved at R 2 betyr en alkylrest med 1-4 C-atomer, fortrinnsvis en metylrest.3. Process according to claim 1 or 2, characterized in that R 2 means an alkyl radical with 1-4 C atoms, preferably a methyl radical. 4. Fremgangsmåte ifølge krav 1-3, karakterisert ved at R betyr en fenyl-eller naftylrest, spesielt en fenylrest, som kan være substituert med 1-2 rettlinjede eller forgrenede alkyl- eller alkenylrester med inntil 8 karbonatomer, spesielt med 1-2 alkylrester med 1-4 karbonatomer, eller fortrinnsvis med 1-2 alkoksygrester med inntil 6 karbonatomer, spesielt med inntil 4 karbonatomer, eller med en cykloalkyl- eller cykloalkenylrest med 5-7 karbonatomer eller med 1-2 halogenatomer som fluor, klor eller brom, eller med 1-2 trifluormetylrester eller med en trifluormetoksy-, nitro-, cyanogruppe eller en dialkylamino-, karbonamido- eller sulfonamidgruppe, hvis nitrogenatom kan være substituert med en eller to rettlinjede eller forgrenede alkylgrupper med respektivt 1-4 C-atomer, og idet ovennevnte alkylgruppe sammen med nitrogenatomet kan danne 5- til 7-leddet heterocyklisk ring, som kan inneholde et oksygenatom som ekstra heteroatom, eller med en SOn~ alkylgruppe, idet n betyr 0-2, spesielt 0 eller 2, og alkylresten er rettlinjet eller forgrenet, og inneholder 1-4 karbonatomer, og idet to substituenter ved fenyl- eller naftylringen sammen kan danne en forgrenet eller uforgrenet, mettet eller umettet 5- til 7-leddet, isocyklisk etter heterocyklisk ring, som kan inneholde 1 svovel- eller 1-2 oksygenatomer.4. Method according to claims 1-3, characterized in that R means a phenyl or naphthyl residue, especially a phenyl residue, which can be substituted with 1-2 straight or branched alkyl or alkenyl residues with up to 8 carbon atoms, especially with 1-2 alkyl residues with 1-4 carbon atoms, or preferably with 1-2 alkoxy residues with up to 6 carbon atoms, especially with up to 4 carbon atoms, or with a cycloalkyl or cycloalkenyl residue with 5-7 carbon atoms or with 1-2 halogen atoms such as fluorine, chlorine or bromine, or with 1-2 trifluoromethyl residues or with a trifluoromethoxy, nitro, cyano group or a dialkylamino, carbonamido or sulfonamide group, whose nitrogen atom may be substituted by one or two linear or branched alkyl groups with respectively 1-4 C atoms, and since the above-mentioned alkyl group together with the nitrogen atom can form a 5- to 7-membered heterocyclic ring, which can contain an oxygen atom as an additional heteroatom, or with a SOn~ alkyl group, where n means 0-2, especially 0 or 2, and the alkyl residue is linear or branched, and contains 1-4 carbon atoms, and since two substituents on the phenyl or naphthyl ring together can form a branched or unbranched, saturated or unsaturated 5- to 7-membered, isocyclic after heterocyclic ring, which can contain 1 sulfur or 1-2 oxygen atoms. 5. Fremgangsmåte ifølge krav 1-4, karakterisert ved at X ■ betyr hydroksyl, en eventuelt forgrenet alkoksygruppe med 1-6 C-atomer, en benzyloksy-, en amino-, alkylamino-eller dialkylaminogruppe med respektivt 1-4 C-atomer pr alkylgruppe, spesielt en alkoksygruppe med 1-3 C-atomer, og Y betyr en alkoksy- eller alkylmerkaptorest med respektivt 1-6 C-atomer i alkylgruppen, en benzyloksy-, fenoksy-, benzylmerkaptorest eller en aminogruppe, spesielt en alkoksyrest med 1-3 C-atomer.5. Method according to claims 1-4, characterized in that X ■ means hydroxyl, an optionally branched alkoxy group with 1-6 C atoms, a benzyloxy group, an amino, alkylamino or dialkylamino group with respectively 1-4 C atoms per alkyl group, especially an alkoxy group with 1-3 C atoms , and Y means an alkoxy or alkylmercaptor residue with respectively 1-6 C atoms in the alkyl group, a benzyloxy, phenoxy, benzylmercaptor residue or an amino group, especially an alkoxy acid residue with 1-3 C atoms. 6. Fremgangsmåte ifølge krav 1-5, karakterisert ved at produktet fra første fremgangsmåtetrinn dessuten i surt miljø ved ekstrahering ved hjelp av et organisk oppløsningsmiddel befries for forurensninger og fortrinnsvis videreomsettes uten isolering direkte i form av en énbeholdersreaksjon i annet fremgangsmåtetrinn.6. Process according to claims 1-5, characterized in that the product from the first process step is also freed from impurities in an acidic environment by extraction with an organic solvent and is preferably further converted without isolation directly in the form of a one-pot reaction in the second process step. 7. Fremgangsmåte ifølge krav 1-6, karakterisert ved at forbindelsen (III) anvendes som salt av en mineralsyre, fortrinnsvis saltsyre.7. Method according to claims 1-6, characterized in that the compound (III) is used as a salt of a mineral acid, preferably hydrochloric acid. 8. Fremgangsmåte ifølge krav 1-7, karakterisert ved at temperaturen under første fremgangsmåtetrinn holdes mellom -20°C og +50°C, fortrinnsvis mellom 10 og 30°C.8. Method according to claims 1-7, characterized in that the temperature during the first method step is kept between -20°C and +50°C, preferably between 10 and 30°C. 9. Fremgangsmåte ifølge krav 1-8, karakterisert ved at reaksjonsbland-ingén i annet fremgangsmåtetrinn inneholder 2-5 vekt-% av et alkali- eller jordalkalihydroksyd, fortrinnsvis NaOH eller KOH.9. Process according to claims 1-8, characterized in that the reaction mixture in the second method step contains 2-5% by weight of an alkali or alkaline earth hydroxide, preferably NaOH or KOH. 10. Fremgangsmåte ifølge krav 1-9, karakterisert ved at reaksjonsbland- - ingen under annet fremgangsmåtetrinn holdes ved -15°C til +5°C, fortrinnsvis ca. 0°C, og reaksjonstiden utgjør mindre enn 1 time.10. Method according to claims 1-9, characterized in that the reaction mixture during the second method step is kept at -15°C to +5°C, preferably approx. 0°C, and the reaction time is less than 1 hour.
NO853732A 1984-10-04 1985-09-23 PROCEDURE FOR PREPARATION OF PYRAZOLONE DERIVATIVES. NO853732L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3436383A DE3436383A1 (en) 1984-10-04 1984-10-04 METHOD FOR PRODUCING PYRAZOLONE DERIVATIVES

Publications (1)

Publication Number Publication Date
NO853732L true NO853732L (en) 1986-04-07

Family

ID=6247066

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853732A NO853732L (en) 1984-10-04 1985-09-23 PROCEDURE FOR PREPARATION OF PYRAZOLONE DERIVATIVES.

Country Status (8)

Country Link
EP (1) EP0180707A1 (en)
JP (1) JPS6191174A (en)
KR (1) KR860003229A (en)
DE (1) DE3436383A1 (en)
DK (1) DK450285A (en)
ES (1) ES8605242A1 (en)
FI (1) FI853816L (en)
NO (1) NO853732L (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738963A1 (en) * 1987-11-17 1989-05-24 Bayer Ag 3-AMINOPYRAZOLINE-5-ONE
JP5597108B2 (en) 2010-11-29 2014-10-01 株式会社精研 Contact inspection jig
EP3497092A1 (en) 2016-08-11 2019-06-19 Bayer CropScience Aktiengesellschaft Substituted pyrazolinyl derivates, method for the production thereof and use thereof as herbicides and/or plant growth regulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2230792A1 (en) * 1972-06-23 1974-01-17 Bayer Ag 3-AMINO-PYRAZOLONE- (5), METHOD FOR MANUFACTURING AND USING IT AS A MEDICINAL PRODUCT
DE2319278C2 (en) * 1973-04-17 1986-02-20 Bayer Ag, 5090 Leverkusen Pharmaceutical agent
DE2363139A1 (en) * 1973-12-19 1975-07-10 Bayer Ag 1-Substd-pyrazol-5-ones - with diuretic, saluretic, antihypertensive and antithrombotic activity
DE2319280A1 (en) * 1973-04-17 1974-11-07 Bayer Ag 1-Substd-pyrazol-5-ones - with diuretic, saluretic, antihypertensive and antithrombotic activity
DE2363138A1 (en) * 1973-12-19 1975-07-10 Bayer Ag 1-Subst-pyrazol-5-ones - with diuretic saluretic, antihypertensive and antithrombotic activity

Also Published As

Publication number Publication date
DE3436383A1 (en) 1986-04-10
KR860003229A (en) 1986-05-21
FI853816L (en) 1986-04-05
JPS6191174A (en) 1986-05-09
ES8605242A1 (en) 1986-03-16
EP0180707A1 (en) 1986-05-14
DK450285D0 (en) 1985-10-03
FI853816A0 (en) 1985-10-02
ES547487A0 (en) 1986-03-16
DK450285A (en) 1986-04-05

Similar Documents

Publication Publication Date Title
SU867298A3 (en) Method of preparing piperidine derivatives or their salts
DK169730B1 (en) Arylimide derivatives and process for the preparation of arylpiperidinecarbinol derivatives
US4152326A (en) Cyclic sulphonyloxyimides
EP0526529B1 (en) An improved process for the preparation of substituted indolone derivatives
SU481155A3 (en) Production method - (furyl-methyl) morphinans
NO752493L (en)
NO138530B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-SUBSTITUTED PYRAZOLONE (5) DERIVATIVES
NO853732L (en) PROCEDURE FOR PREPARATION OF PYRAZOLONE DERIVATIVES.
NO151387B (en) SETTING DEVICE FOR AN ELECTRONIC DIGITAL INDICATOR
SU1041033A3 (en) Process for preparing derivatives of aminopropanol or their salts
NO166712B (en) PROCEDURE FOR THE PREPARATION OF PYRROLIDO DERIVATIVES.
SU588917A3 (en) Method of preparing 1-/2(b-naphthyloxy)-ethyl/-3-methylpyrazolone-5
US4958029A (en) Process for the production of isoindoline derivatives, novel intermediates and process for their production
US4151210A (en) Process for the production of phenylalkyl sulphones
US4429117A (en) Process for the production of known and new 6-amino-6-desoxy-2,3-O-isopropylidene-α-L-sorbofuranose derivatives, and intermediate products of the process
US4292431A (en) Process for the production of hydroxymethylimidazoles
SU576955A3 (en) Method of preparing adenosine derivatives
NO115019B (en)
DK156391B (en) ANALOGY PROCEDURE FOR PREPARING 3-AMINOPYR ROLLER DERIVATIVES
SU528871A3 (en) The method of obtaining derivatives of 2- (1H) -quinazolinone
NO134767B (en)
US4477677A (en) Process for the preparation of 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxyacetic acid
SU527136A3 (en) The method of obtaining pyridohinolinovy esters
SU342347A1 (en) METHOD OF OBTAINING IMIDAZOZIDIDINONE DERIVATIVES
US4459415A (en) Process for the preparation of 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxyacetic acid